News
Explore the transformative field of genomics with the power to solve humanity's greatest challenges and shape the future.
China's rapid rise in biotechnology poses a national security threat, urging the U.S. to invest heavily in innovation and ...
Hosted on MSN13d
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocksincluding 10x Genomics (NASDAQ:TXG) and its peers. The life sciences tools and services sector supports the research, ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform ...
The latest biotech industry updates, complete with product launches, partnerships, publications and personnel appointments ...
Global X Genomics & Biotechnology ETF has a twelve month low of $8.31 and a twelve month high of $11.88. The stock has a market cap of $58.20 million, a P/E ratio of -3.57 and a beta of 1.03.
Genetic Networks, a wholly owned subsidiary of Fifty 1 Labs, Inc., specializes in genetic profiling and bioinformatics, delivering transformative insights into biological systems. Led by experts like ...
Biotechnology Reagents Market As per MRFR analysis, the Biotechnology Reagents Market Growth Size was estimated at 44.6 (USD Billion) in 20 ...
including 10x Genomics (NASDAQ:TXG) and its peers. The life sciences tools and services sector supports the research, development, and commercialization of biotechnology and pharmaceutical products.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results